165 related articles for article (PubMed ID: 35150860)
1. A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis.
Zhang J; Yu G; Yang Y; Wang Y; Guo M; Yin Q; Yan C; Tian J; Fu F; Wang H
Pharmacol Res; 2022 Mar; 177():106128. PubMed ID: 35150860
[TBL] [Abstract][Full Text] [Related]
2. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
[TBL] [Abstract][Full Text] [Related]
3. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.
Clemente-Soto AF; Salas-Vidal E; Milan-Pacheco C; Sánchez-Carranza JN; Peralta-Zaragoza O; González-Maya L
Mol Med Rep; 2019 Mar; 19(3):2097-2106. PubMed ID: 30664221
[TBL] [Abstract][Full Text] [Related]
4. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
[TBL] [Abstract][Full Text] [Related]
5. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
Talis AL; Huibregtse JM; Howley PM
J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
[TBL] [Abstract][Full Text] [Related]
6. Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6.
Wang H; Mo P; Ren S; Yan C
J Biol Chem; 2010 Apr; 285(17):13201-10. PubMed ID: 20167600
[TBL] [Abstract][Full Text] [Related]
7. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.
Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ
PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816
[TBL] [Abstract][Full Text] [Related]
8. Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.
Sailer C; Offensperger F; Julier A; Kammer KM; Walker-Gray R; Gold MG; Scheffner M; Stengel F
Nat Commun; 2018 Oct; 9(1):4441. PubMed ID: 30361475
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation.
Li S; Hong X; Wei Z; Xie M; Li W; Liu G; Guo H; Yang J; Wei W; Zhang S
Front Microbiol; 2019; 10():2483. PubMed ID: 31749782
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HPV E7 Stability by E6-Associated Protein (E6AP).
Vats A; Trejo-Cerro O; Massimi P; Banks L
J Virol; 2022 Aug; 96(16):e0066322. PubMed ID: 35916535
[TBL] [Abstract][Full Text] [Related]
11. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
[TBL] [Abstract][Full Text] [Related]
12. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
[TBL] [Abstract][Full Text] [Related]
14. Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation.
Altamura G; Power K; Martano M; Degli Uberti B; Galiero G; De Luca G; Maiolino P; Borzacchiello G
Sci Rep; 2018 Dec; 8(1):17529. PubMed ID: 30510267
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
Alarcón R; Koumenis C; Geyer RK; Maki CG; Giaccia AJ
Cancer Res; 1999 Dec; 59(24):6046-51. PubMed ID: 10626788
[TBL] [Abstract][Full Text] [Related]
16. HPV E6, E6AP and cervical cancer.
Beaudenon S; Huibregtse JM
BMC Biochem; 2008 Oct; 9 Suppl 1(Suppl 1):S4. PubMed ID: 19007434
[TBL] [Abstract][Full Text] [Related]
17. Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding.
Cho Y; Cho C; Joung O; Lee K; Park S; Yoon D
Antiviral Res; 2000 Sep; 47(3):199-206. PubMed ID: 10974372
[TBL] [Abstract][Full Text] [Related]
18. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
19. Identification of MicroRNAs That Stabilize p53 in Human Papillomavirus-Positive Cancer Cells.
Martínez-Noël G; Szajner P; Kramer RE; Boyland KA; Sheikh A; Smith JA; Howley PM
J Virol; 2022 Feb; 96(4):e0186521. PubMed ID: 34878887
[TBL] [Abstract][Full Text] [Related]
20. The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.
Kelley ML; Keiger KE; Lee CJ; Huibregtse JM
J Virol; 2005 Mar; 79(6):3737-47. PubMed ID: 15731267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]